Viewing Study NCT06594068


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2025-12-24 @ 5:55 PM
Study NCT ID: NCT06594068
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-09-10
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module